Skip to main content

Advertisement

Table 2 Characteristics of HIV-related services in buprenorphine treatment reported as mean (standard deviation) or percentage (count)

From: A mixed methods study of HIV-related services in buprenorphine treatment

  Mean (SD) or % (N) 95% CI N
Intake practicesa
 All new patients are asked about frequency of injection drug use 92.4% (1055) 90.8–93.9 1142
 All new patients are asked about sharing of syringes 82.9% (944) 80.7–85.1 1139
 All new patients are asked about sharing of non-syringe drug paraphernalia (e.g., straws, cottons, cookers) 53.2% (604) 50.3–56.1 1136
 All new patients are asked about number of sexual partners 48.0% (548) 45.1–50.9 1141
 All new patients are asked about frequency of unprotected sexual intercourse 48.5% (554) 45.6–51.4 1142
 Count of intake practices 3.2 (1.6) 3.1–3.3 1127
HIV education
 Physician delivers HIV/AIDS education to his/her patientsa 62.0% (709) 59.2–64.8 1144
 Patient education emphasis on how HIV/AIDS is transmittedb 2.0 (1.9) 1.9–2.2 1136
 Patient education emphasis on the importance of not sharing syringesb 2.5 (2.2) 2.4–2.6 1137
 Patient education emphasis on the importance of not sharing other drug paraphernaliab 2.1 (2.1) 1.9–2.2 1136
 Patient education emphasis on development of safer sex practicesb 2.1 (2.0) 2.0–2.2 1132
 Patient education emphasis on skill rehearsal of correct condom useb 0.7 (1.4) 0.7–0.8 1335
 Patient education emphasis on practicing partner communication and negotiation skills about safer sex practicesb 1.0 (1.5) 1.0–1.1 1133
 Mean scale of patient education 1.7 (1.6) 1.7–1.8 1127
HIV testinga
 Recommend that all new patients be tested for HIV/AIDS 53.2% (610) 50.3–56.1 1146
 On-site HIV testing (rapid or non-rapid) 32.3% (370) 29.5–35.0 1147
  1. Notes. aDichotomous measures (1 = yes, 0 = no). bLikert responses (0 = no extent to 5 = very great extent)